Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.37 - $1.69 $34,990 - $159,823
-94,570 Reduced 63.54%
54,268 $42,000
Q2 2023

Aug 11, 2023

BUY
$0.39 - $1.69 $24,941 - $108,080
63,953 Added 75.34%
148,838 $58,000
Q1 2023

May 11, 2023

BUY
$1.75 - $3.14 $138,409 - $248,345
79,091 Added 1365.05%
84,885 $148,000
Q4 2022

Feb 13, 2023

SELL
$2.09 - $4.32 $2.41 Million - $4.99 Million
-1,154,643 Reduced 99.5%
5,794 $13,000
Q3 2022

Nov 14, 2022

BUY
$2.24 - $4.18 $2.59 Million - $4.83 Million
1,156,023 Added 26189.92%
1,160,437 $3.17 Million
Q2 2022

Aug 11, 2022

SELL
$2.85 - $7.77 $2.33 Million - $6.36 Million
-818,019 Reduced 99.46%
4,414 $12,000
Q1 2022

May 11, 2022

BUY
$5.7 - $9.3 $404,295 - $659,639
70,929 Added 9.44%
822,433 $6.23 Million
Q4 2021

Feb 10, 2022

SELL
$8.73 - $15.27 $488,303 - $854,112
-55,934 Reduced 6.93%
751,504 $6.56 Million
Q3 2021

Nov 12, 2021

BUY
$13.52 - $23.95 $10.9 Million - $19.3 Million
807,438 New
807,438 $11.2 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $2.12B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.